Zhejiang Huayuan Auto Technology
301535
Zhejiang Huaye Plastics Machinery
301616
SANWEI CO.,LTD.
831834
THEC
833509
Huarong Chemical
301256
CN Stock MarketDetailed Quotes
600713 Nanjing Pharmaceutical
- 5.10
- +0.01+0.20%
Not Open Mar 27 15:00 CST
6.68BMarket Cap11.51P/E (TTM)
5.11High5.05Low82.57KlotVolume5.08Open5.09Pre Close41.98MTurnover0.63%Turnover Ratio11.56P/E (Static)1.31BShares5.6452wk High0.99P/B6.64BFloat Cap4.0652wk Low5.60Limit Up1.30BShs Float19.62Historical High4.58Limit Down1.18%Amplitude-0.27Historical Low0.16Dividend TTM5.08Avg Price30.22KlotAsk3.14%Div YieldTTM100Lot Size49.84KlotBid
Nanjing Pharmaceutical News
Nanjing Pharmaceutical\'s Repurchase Report on the Repurchase of Shares Using Centralized Bidding Transactions
Announcement of Nanjing Pharmaceutical on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Announcement of Nanjing Pharmaceutical on obtaining stock repurchase loan support from financial institutions
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on Nanjing Pharmaceutical Co., Ltd.\'s 2025 Restricted Stock Incentive Plan
Nanjing Pharmaceutical 2025 Restricted Stock Incentive Plan (Draft) Summary Announcement
Inspection opinions of the Nanjing Pharmaceutical Supervisory Board on matters related to the company\'s 2025 restricted stock incentive plan
Announcement of Nanjing Pharmaceutical on plans to repurchase shares through centralized bidding
Nanjing Pharmaceutical 2025 Restricted Stock Incentive Plan (Draft)
Nanjing Pharmaceutical\'s 2025 Restricted Stock Incentive Plan grants a list of incentive recipients for the first time
Nanjing Pharmaceutical\'s announcement on the listing and circulation of restricted non-public shares in 2021
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan was granted for the first time to release part of the second restricted stock release and listing announcement
Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan granted part of the second share release and listing announcement for the lifting of sales restrictions
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on the company\'s 2021 Restricted Stock Incentive Plan for the first time to grant part of the second period of lifting the sales restriction period and the achievement of lifting the sales restriction conditions
Nanjing Pharmaceutical: Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the company\'s 2021 restricted stock incentive plan granted part of the second sales restriction period to lift the sales restriction list for the first time
Nanjing Pharmaceutical: Legal Opinion from the Shanghai Branch of Beijing Jingtian Gongcheng Law Firm on the Company\'s 2021 Restricted Stock Incentive Plan for the First Time Granting Part II of the Sales Restriction Period and the Achievement of Lifting the Conditions of Cancellation of Sales Restrictions
Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan granted part of the second sales restriction period to lift the sales restriction list for the first time
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the Company\'s 2021 Restricted Stock Incentive Plan for the First Time Granting Part 2 of the Sales Restriction Period and Achievements in Releasing the Conditions of Sale Restriction
Announcement of Nanjing Pharmaceutical on the Company\'s 2021 Restricted Stock Incentive Plan for the first time and the achievement of lifting sales restrictions during the second period of lifting sales restrictions
Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first stock release and listing announcement for the lifting of sales restrictions
Nanjing Pharmaceutical: Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first sales restriction period to lift the sales restriction list
